Task Evidence
CHIMERA2025 · brs_risk_group (CHIMERA2025__BRS)
Risk, Response & Prognosis / Treatment Response & Residual Disease
Inspect benchmark evidence for one task at a time: who leads, how stable the split-level results are, and which neighbouring tasks are likely to transfer intuition.
clsL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual DiseasebladderH&EAnchor evidence
Task metadata
Fields sourced from benchmark_main. Missing values are shown as —.
Identity
- task_key
- CHIMERA2025__BRS
- dataset_name
- CHIMERA2025
- task_name
- brs_risk_group
- task_type
- cls
Taxonomy
- task_family_l1
- Risk, Response & Prognosis
- task_family_l2
- Treatment Response & Residual Disease
- label_structure
- multiclass
- num_classes
- 3
- labels
- {"0": "BRS2", "1": "BRS3", "2": "BRS1"}
Biology
- organ
- bladder
- stain
- H&E
- specimen_type
- resection
- timepoint
- pre_treatment
- disease
- 膀胱癌
Scale & Labels
- patient_n
- 131
- slide_n
- 131
- label_source
- molecular_omics
- label_visibility
- indirect
Result Evidence
- result_tier
- Anchor
- result_quality_score
- 93.4
- result_flags
- —
- result_tier_reason
- Clear model separation: significant-win density 0.255.Difficulty sits in a usable range: best mean 0.733.
loading…
Similar tasks
Ranked by shared L2 subtype first, then L1 family, organ, type and label structure.
- BC-Therapy · residual_cancer_burdenL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseasebreastclsscore 10has results
- HER2-Tumor-ROIs · treatment_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseasebreastclsscore 10has results
- MBC · recist_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseasebreastclsscore 10has results
- OV-Bevacizumab · treatment_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseaseovaryclsscore 10has results
- PTRC-HGSOC · treatment_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseaseovaryclsscore 10has results
- PTRC-HGSOC · tumor_stageL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseaseovaryclsscore 10has results
- CHIMERA2025 · progression_statusL1 · Risk, Response & PrognosisL2 · Survival, Recurrence & Progression Outcomesbladderclsscore 9has results
- NADT-Prostate · treatment_responseL1 · Risk, Response & PrognosisL2 · Treatment Response & Residual Diseaseprostateclsscore 9has results